Cambridge Respiratory Innovations (CRI) creates ground-breaking respiratory technologies. In December 2020 it received funding from BGF and Downing Ventures to fast track research and development of its award-winning N-Tidal device to help medical professionals diagnose and monitor respiratory conditions. The N-Tidal device is a first-in-kind, connected, handheld capnometer incorporating unique patented sensor technology, that can accurately measure carbon dioxide levels in exhaled breath during normal breathing.
Business funding insights
BGF explains: Is private equity the best way to fund an M&A growth strategy?
What to consider when seeking private equity funding for acquisitive growth, from investment timelines to deal types and more
BGF explains: what do private equity investors look for in a business?
We explain what private equity investors look for in the businesses they invest in, from your growth plan to your management team.